| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
182 |
| issn |
1478-7210
1744-8336 |
| issueIdentifier |
1 |
| pageRange |
175-182 |
| publicationName |
Expert Review of Anti-infective Therapy |
| startingPage |
175 |
| bibliographicCitation |
Petersen E, Schmidt DR. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? Expert Rev Anti Infect Ther. 2003 Jun;1(1):175–82. doi: 10.1586/14787210.1.1.175. PMID: 15482110. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ba208734c6ab1edf926383ac55ecfc5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a28a9859fafdbe46b4711d53ddf4453c |
| date |
200306 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/15482110
https://doi.org/10.1586/14787210.1.1.175 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32025
https://portal.issn.org/resource/ISSN/1478-7210
https://portal.issn.org/resource/ISSN/1744-8336 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? |
| discusses |
http://id.nlm.nih.gov/mesh/M0018253
http://id.nlm.nih.gov/mesh/M0020740 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D013411Q000627
http://id.nlm.nih.gov/mesh/D014125Q000188
http://id.nlm.nih.gov/mesh/D011739Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D007231 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446598
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5215 |